{
    "url_original": "https://www.wsj.com/articles/covid-19-pill-developer-to-spend-spac-ipo-funds-on-clinical-trial-hiring-11641983403?mod=business_lead_pos4",
    "url": "covid-19-pill-developer-to-spend-spac-ipo-funds-on-clinical-trial-hiring-11641983403",
    "title": "Covid-19 Pill Developer to Spend SPAC IPO Funds on Clinical Trial, Hiring",
    "sub_head": "Pardes Biosciences listed on Nasdaq late last month after merging with a blank-check company",
    "category_1": "CFO Journal",
    "image_1_url": "https://images.wsj.net/im-465112?width=639&height=426",
    "image_1": "im-465112.jpg",
    "time": "2022-01-12 05:30:00"
}